Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 1/2 3Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myeloid, Acute 143Myelodysplastic Syndromes 53Leukemia 24Leukemia, Myelomonocytic, Chronic 21Recurrence 12Myeloproliferative Disorders 7Leukemia, Biphenotypic, Acute 7Carcinoma, Non-Small-Cell Lung 7Lymphoma, T-Cell, Peripheral 6Leukemia, Monocytic, Acute 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm, Residual 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Acute 5Anemia, Refractory, with Excess of Blasts 5Neoplasms 4Leukemia, Erythroblastic, Acute 4Congenital Abnormalities 4Prostatic Neoplasms 3Primary Myelofibrosis 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Pancreatic Neoplasms 2

Interventions

Cyclophosphamide 27Busulfan 25fludarabine phosphate 24Antilymphocyte Serum 20Tacrolimus 18Peripheral Blood Stem Cell Transplantation 18Cyclosporine 15Radiotherapy 14Mycophenolic Acid 14Methotrexate 14Melphalan 12Filgrastim 11Whole-Body Irradiation 10Methylprednisolone 10Cord Blood Stem Cell Transplantation 9Etoposide 7Cytarabine 5sargramostim 4Thiotepa 4Thalidomide 4Specimen Handling 4Sirolimus 4Rituximab 4Cyclosporins 4Biopsy 4Alemtuzumab 4ruxolitinib 3Flow Cytometry 3Arsenic Trioxide 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Myelodysplastic-Myeloproliferative Diseases × Azacitidine × Clear all
NCT05282719 2022-03-16

Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults

The First Affiliated Hospital of Soochow University

Phase 2 Unknown
33 enrolled
Myeloid

Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡